News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,111 Results
Type
Article (41598)
Company Profile (463)
Press Release (659050)
Section
Business (208401)
Career Advice (2004)
Deals (35943)
Drug Delivery (92)
Drug Development (83301)
Employer Resources (169)
FDA (16325)
Job Trends (15045)
News (352089)
Policy (32979)
Tag
Academia (2619)
Alliances (50609)
Alzheimer's disease (1273)
Approvals (16250)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11733)
Biotechnology (349)
Breast cancer (124)
Cancer (1115)
Cardiovascular disease (102)
Career advice (1673)
Cell therapy (248)
Clinical research (66000)
Collaboration (408)
Compensation (199)
COVID-19 (2590)
C-suite (100)
Data (1138)
Diabetes (156)
Diagnostics (6197)
Earnings (86044)
Employer resources (147)
Events (112927)
Executive appointments (316)
FDA (16871)
Funding (366)
Gene therapy (193)
GLP-1 (611)
Government (4409)
Healthcare (18995)
Infectious disease (2675)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16573)
Job creations (3694)
Job search strategy (1429)
Layoffs (439)
Legal (7928)
Lung cancer (174)
Manufacturing (181)
Medical device (13322)
Medtech (13327)
Mergers & acquisitions (19434)
Metabolic disorders (426)
Neuroscience (1564)
NextGen Class of 2024 (6734)
Non-profit (4532)
Northern California (1496)
Obesity (245)
Opinion (198)
Patents (103)
People (57631)
Phase I (20682)
Phase II (29138)
Phase III (21546)
Pipeline (459)
Postmarket research (2590)
Preclinical (8882)
Radiopharmaceuticals (252)
Rare diseases (234)
Real estate (5998)
Regulatory (21956)
Research institute (2403)
Resumes & cover letters (351)
Southern California (1324)
Startups (3747)
United States (13873)
Vaccines (565)
Weight loss (183)
Date
Today (132)
Last 7 days (819)
Last 30 days (3886)
Last 365 days (36710)
2024 (33681)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47421)
2018 (35698)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29221)
2011 (29863)
2010 (27993)
Location
Africa (731)
Arizona (200)
Asia (38513)
Australia (6402)
California (3418)
Canada (1293)
China (252)
Colorado (148)
Connecticut (162)
Europe (83995)
Florida (462)
Georgia (116)
Illinois (354)
Indiana (199)
Kansas (99)
Maryland (590)
Massachusetts (2726)
Michigan (159)
Minnesota (278)
New Jersey (970)
New York (973)
North Carolina (759)
Northern California (1496)
Ohio (141)
Pennsylvania (852)
South America (1105)
Southern California (1324)
Texas (476)
Utah (92)
Washington State (374)
701,111 Results for "trillium therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
Bayer announced today initiation of dosing in a Phase I first-in-human clinical study with 225Ac-PSMA-Trillium (BAY 3563254), a next-generation targeted alpha therapy.
May 15, 2024
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
November 21, 2024
·
4 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Deals
Pfizer to Acquire Trillium Therapeutics Inc.
Pfizer Inc. and Trillium Therapeutics Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.
August 23, 2021
·
14 min read
Press Releases
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
October 28, 2024
·
8 min read
1 of 70,112
Next
